| Literature DB >> 26552331 |
David J Polman1, Douglas K Price1, William D Figg1.
Abstract
A new bigenic mouse model, engineered with the overexpression of PSGR and the knockout of PTEN, has been used to study the relationship between 2 genes and disease progression. A study in Oncogene (Rodriguez et al.) has shown that these 2 genetic polymorphisms synergistically promote the development of prostate cancer.Entities:
Keywords: NF-κB pathway; PIK3/Akt pathway; PSGR; PTEN; bigenic mouse model; disease progression; genetic synergism; prostate cancer
Year: 2015 PMID: 26552331 PMCID: PMC4847822 DOI: 10.1080/15384047.2015.1108498
Source DB: PubMed Journal: Cancer Biol Ther ISSN: 1538-4047 Impact factor: 4.742